AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
12.11.24
/
50%
€20.20
Target price
12.11.25
€62.23
Performance (%)
37.62%
End price
13.11.25
€27.80
Summary
This prediction ended on 13.11.25 with a price of €27.80. The BUY prediction by JPMorgan_Chase___Co_ for AnaptysBio Inc saw massive gains of 37.62%. JPMorgan_Chase___Co_ has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -2.165% | -2.165% | 216.084% |
| iShares Core DAX® | -3.809% | -1.472% | 6.060% |
| iShares Nasdaq 100 | 0.487% | 2.215% | 12.682% |
| iShares Nikkei 225® | -4.418% | 4.971% | 30.914% |
| iShares S&P 500 | 0.251% | 1.225% | 9.374% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $75.00 to $66.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten